Brossier Lab

Exploring genetic, environmental and developmental influences on glioma formation and cognitive impairment, our lab investigates how these factors shape risk in patients with Neurofibromatosis Type 1 and the broader pediatric population. Using murine models as a platform, we aim to uncover mechanisms driving tumor development and neurodevelopmental changes, identify new strategies for patient risk assessment and discover therapeutic targets. Through this work, we strive to transform understanding and improve outcomes for children affected by NF1 and related conditions.